About chornixadm

This author has not yet filled in any details.
So far chornixadm has created 66 blog entries.

Oellerich M et al. Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation. Ther Drug Monit. 2014 Apr;36(2):136-40

By | September 27th, 2018|Medical publications, Transplant|0 Comments

Schütz E et al. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study. PLoS Med (2017) 14: e1002286

By | September 27th, 2018|Medical publications, Transplant|0 Comments

Beck J et al. Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury. Clin Chem. 2013 Dec;59(12):1732-41

By | September 27th, 2018|Medical publications, Transplant|0 Comments

Kanzow P et al. Graft-derived cell-free DNA as an early organ integrity biomarker after transplantation of a marginal HELLP syndrome donor liver. Transplantation. 2014 Sep 15;98(5):e43-5

By | September 27th, 2018|Medical publications, Transplant|0 Comments

Oellerich M et al. Graft-Derived Cell-Free DNA as a Marker of Transplant Graft Injury. Ther Drug Monit. 2016 Apr;38 Suppl 1:S75-9

By | September 27th, 2018|Medical publications, Transplant|0 Comments

Beck J, et al. Profile of the circulating DNA in apparently healthy individuals. Clin Chem. 2009 Apr;55(4):730-8

By | September 27th, 2018|Cancer, Medical publications|0 Comments

Beck J et al. Genome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA. PLoS One. 2013 Sep 30;8(9):e75485

By | September 27th, 2018|Cancer, Medical publications|0 Comments

Oellerich M et al. Using Circulating Cell-free DNA to Monitor Personalized Cancer Therapy. Crit. Rev. Clin. Lab. Sci 2017; 54:205-218

By | September 27th, 2018|Cancer, Medical publications|0 Comments

Beck J et al. Next generation sequencing of serum circulating nucleic acids from patients with invasive ductal breast cancer reveals differences to healthy and nonmalignant controls. Mol Cancer Res. 2010 Mar;8(3):335-42.

By | September 27th, 2018|Cancer, Medical publications|0 Comments

Schütz E et al. Chromosomal instability in cell-free DNA is a serum biomarker for prostate cancer. Clin Chem. 2015 Jan;61(1):239-48

By | September 27th, 2018|Cancer, Medical publications|0 Comments